Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cristina E Tognon

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Biology of the Cell|January 30, 2015
Detecting and targetting oncogenic fusion proteins in the genomic eraMonika A Davare, Cristina E Tognon
Expert Opinion on Therapeutic Targets|January 14, 2012
Targeting the insulin-like growth factor 1 receptor (IGF1R) signaling pathway for cancer therapyCristina E Tognon, Poul H B Sorensen
Seminars in Cancer Biology|May 5, 2012
On translational regulation and EMTValentina Evdokimova, Cristina E Tognon, Poul H B Sorensen
Leukemia|September 26, 2019
Revisiting NTRKs as an emerging oncogene in hematological malignanciesSunil K Joshi, Monika A Davare, Brian J Druker, et al.
Journal of Pediatric Hematology/Oncology|September 15, 2017
Novel Method Enabling the Use of Cryopreserved Primary Acute Myeloid Leukemia Cells in Functional Drug ScreensMichelle Degnin, Anupriya Agarwal, Katherine Tarlock, et al.
Cold Spring Harbor Molecular Case Studies|January 26, 2020
Functional characterization of two rare BCR-FGFR1<sup>+</sup> leukemiasEvan J Barnes, Jessica Leonard, Bruno C Medeiros, et al.
Oncogene|August 13, 2002
ETV6-NTRK3 transformation requires insulin-like growth factor 1 receptor signaling and is associated with constitutive IRS-1 tyrosine phosphorylationKevin B Morrison, Cristina E Tognon, Mathew J Garnett, et al.
Annual Review of Cancer Biology|July 5, 2021
<i>Ex Vivo</i> Analysis of Primary Tumor Specimens for Evaluation of Cancer TherapeuticsCristina E Tognon, Rosalie C Sears, Gordon B Mills, et al.
Molecular and Cellular Biology|May 15, 2004
Mutations in the SAM domain of the ETV6-NTRK3 chimeric tyrosine kinase block polymerization and transformation activityCristina E Tognon, Cameron D Mackereth, Aruna M Somasiri, et al.
Oncotarget|August 6, 2020
Genomic markers of midostaurin drug sensitivity in FLT3 mutated and FLT3 wild-type acute myeloid leukemia patientsMara W Rosenberg, Kevin Watanabe-Smith, Jeffrey W Tyner, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Biology of the Cell|January 30, 2015
Detecting and targetting oncogenic fusion proteins in the genomic eraMonika A Davare, Cristina E Tognon
Expert Opinion on Therapeutic Targets|January 14, 2012
Targeting the insulin-like growth factor 1 receptor (IGF1R) signaling pathway for cancer therapyCristina E Tognon, Poul H B Sorensen
Seminars in Cancer Biology|May 5, 2012
On translational regulation and EMTValentina Evdokimova, Cristina E Tognon, Poul H B Sorensen
Leukemia|September 26, 2019
Revisiting NTRKs as an emerging oncogene in hematological malignanciesSunil K Joshi, Monika A Davare, Brian J Druker, et al.
Journal of Pediatric Hematology/Oncology|September 15, 2017
Novel Method Enabling the Use of Cryopreserved Primary Acute Myeloid Leukemia Cells in Functional Drug ScreensMichelle Degnin, Anupriya Agarwal, Katherine Tarlock, et al.
Cold Spring Harbor Molecular Case Studies|January 26, 2020
Functional characterization of two rare BCR-FGFR1<sup>+</sup> leukemiasEvan J Barnes, Jessica Leonard, Bruno C Medeiros, et al.
Oncogene|August 13, 2002
ETV6-NTRK3 transformation requires insulin-like growth factor 1 receptor signaling and is associated with constitutive IRS-1 tyrosine phosphorylationKevin B Morrison, Cristina E Tognon, Mathew J Garnett, et al.
Annual Review of Cancer Biology|July 5, 2021
<i>Ex Vivo</i> Analysis of Primary Tumor Specimens for Evaluation of Cancer TherapeuticsCristina E Tognon, Rosalie C Sears, Gordon B Mills, et al.
Molecular and Cellular Biology|May 15, 2004
Mutations in the SAM domain of the ETV6-NTRK3 chimeric tyrosine kinase block polymerization and transformation activityCristina E Tognon, Cameron D Mackereth, Aruna M Somasiri, et al.
Oncotarget|August 6, 2020
Genomic markers of midostaurin drug sensitivity in FLT3 mutated and FLT3 wild-type acute myeloid leukemia patientsMara W Rosenberg, Kevin Watanabe-Smith, Jeffrey W Tyner, et al.
Pageof 6